The nitty gritty on compensation starts on page 27 of Gilead’s proxy document. Its compensation mix for Gilead’s executive group is skewed towards equity awards that are over 200% of base salary and annual bonus opportunity. On page 34 it’s noted that Gilead’s CEO John Martin took home more than $90 million making him one of the 10 highest paid CEO’s in the country. His 5-year compensation exceeded $250 million, top man in the pharma sector. Generous options and stock grants fueled by marked equity appreciation in Gilead told the story.
**************************
There is no qualm in Gilead
To make the top man whole;
There is no qualm in Gilead
To heal the CEO.
Sovaldi costs a thousand
Martin’s work is not in vain,
He took that balm in Gilead
And made it pay and pay.
There is no qualm in Gilead
To make the top man whole;
There is no qualm in Gilead
To heal the CEO.
If I can’t earn like Martin
If I can’t take his take home
Then take me home to Jesus,
And say I died alone.